Analyst Ratings for Amneal Pharmaceuticals (AMRX)
AMRX Rating Summary
AMRX Price Target Summary
- Highest: $19.00 (UBS)
- Lowest: $13.00 (Piper Sandler)
- Average: $16.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$16.60 (+2.4%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
Avg. $ Target:
$16.60 (+2.4%)
* Over Last 12-Mos
Rating Score: 5.5 / 10
Percentile Rank: 58%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/17/2026 | UBS | Ashwani Verma | New Coverage | Buy (N/A) |
19.00 (N/A) |
13.05 (16.21) |
24.21% | Details |
| 12/9/2025 | Barclays » Updated 5/20/2026 |
Glen Santangelo | New Coverage | Overweight (N/A) |
16.00 (15.00) |
12.18 (16.21) |
33.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
